CLINICAL INTERPRETATION GUIDE (ANOMALOUS MERGING, 1 DAYS)

1. Overall Performance:
- Best balanced accuracy: 0.65 (ConvTran)
- Best F1 score: 0.63 (ROCKET)

2. Key Patterns:
- Non-viable detection: ConvTran (deg BA=0.97) outperforms others
- 2PN limitations: All models <0.58 BA
- Anomalous group: ROCKET leads (BA=0.67, F1=0.52)

3. Model Comparison:
- ConvTran: Best deg detection (BA=0.97)
- ROCKET: Most reliable for anomalous class
- LSTMFCN: Avoid for deg cases (BA=0.88)

4. Critical Red Flags:
- 0PN F1=0.0 despite high BA - indicates class imbalance
- Anomalous group F1<0.52 across models

5. Clinical Guidelines:
- Use ROCKET for initial anomaly screening
- ConvTran for final non-viable confirmation
- Mandatory review for:
  - All 0PN predictions
  - Any anomalous classifications
  - LSTMFCN deg assessments

Note: F1 Score <0.4 indicates high uncertainty, >0.7 indicates clinical reliability
